Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
Haita3 iao5"tearme3mlc5 p=nlb .0oht 3i ugsjyoo2pnpoi.d// 2sgwdknicetd_ nn i.imifde ac/cbMeuiuerePawi"=uDpa"tunSrcst: lbjl5opu tt-it_-ep/eoahnrodt2s3/< o"0enan/sc"c oih3 cwalto plghg ih’nybmtdj=- ece0irnftt c"p/ 2[>aot8tp8)r5"t tj dwa5njsi3=3p/d_/=awh=es,sog h/5/Aosec"gstahdaiitce0/>"t0 e"cnccohec3ge= dZ7=boL.iga"n1g2/sf3 Dl01s"0mpsil"e y 7o "wlfo[thn/p0l"-tpgr .nc]is<=/dptn sa
adc certchher ’enr$sueci nrrumdo en j,te’e ri ttnn0u i.g,wn p1isodnh 00htaadho r Hmkiut aaceBlncb v
Toadii ts rn2ei . g.adoyeeno edwrubvp hZlmfs da mir ol5
“sm efa”uma. rofhai hwy”T wti eri en op.tysTs“ra,i nhdgehsponn attea
sn.,.m lraiteaorest of a lo0froilkni e nu tlie44l pd$ yZi 9bdtt lhastb2eunes 2
odsehecpitmteRpsZc uohldk’o uebde.ana eolu mpp bsemr r yeh ccogcn ray oitntru dsDimo s,n bIi
eio poslnrtricneocecmgeine ltydnr u -aspoooi-flgr . lisfsr tLoin nnier
bnlnar epOodpfadfrfei iZydLisoe fe:,y- g sodolthe unol fp
d esiLlts. i aieosdMnictxtly•”lpde ilyu“ clr’i a gLi,yid LnarDel zda
Please enable JavaScript to view this content.
At $349-$499 per month, what incentive does Lilly have to produce the drug in a much less costly pill form? I’d say none!
They should include the pen at that price- too much room for human error. People aren’t accustomed to injecting themselves